SkinHealth Systems (SKIN) Convertible Debt (2021 - 2026)

SkinHealth Systems (SKIN) has 6 years of Convertible Debt data on file, last reported at $344.2 million in Q1 2026.

• Convertible Debt for Q1 2026 came in at $344.2 million, down 37.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $344.2 million (down 37.75% YoY), and the FY2025 annual result was $240.4 million, down 56.46% from the prior year.
• Convertible Debt rose to $344.2 million in Q1 2026 per SKIN's latest filing, from $240.4 million in the prior quarter.
• Over five years, Convertible Debt peaked at $738.4 million in Q4 2023 and troughed at $240.4 million in Q4 2025.
• A 5-year average of $591.8 million and a median of $665.5 million in 2024 frame the typical range for Convertible Debt.
• The sharpest annual moves came in 2022 and 2025: Convertible Debt grew 0.58% in 2022, then sank 56.46% in 2025.
• A 5-year view of Convertible Debt shows it stood at $734.1 million in 2022, then advanced by 0.58% to $738.4 million in 2023, then decreased by 25.21% to $552.2 million in 2024, then slumped by 56.46% to $240.4 million in 2025, then soared by 43.17% to $344.2 million in 2026.
• Business Quant data shows SKIN's Convertible Debt at $344.2 million in Q1 2026, $240.4 million in Q4 2025, and $363.4 million in Q3 2025.